PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 1 day 18 hours 9 minutes
"Management Strategies to Alleviate the OFF Episodes in Parkinson's Disease"
"Management Strategies to Alleviate the OFF Episodes in Parkinson's Disease"
Acute Psychosis: When to Suspect Acute Hepatic Porphyria
Acute Psychosis: When to Suspect Acute Hepatic Porphyria
Suspecting, Diagnosing and Managing Multifocal Motor Neuropathy: A Patient Investigation
Suspecting, Diagnosing and Managing Multifocal Motor Neuropathy: A Patient Investigation
If I'd Known Then What I Know Now: Recognising My First AHP Patient
If I'd Known Then What I Know Now: Recognising My First AHP Patient
"Menstruation Triggering Severe Unexplained Abdominal Pain: Could It Be Acute Hepatic Porphyria?"
"Menstruation Triggering Severe Unexplained Abdominal Pain: Could It Be Acute Hepatic Porphyria?"
Acute Polyneuropathy With Abdominal Pain: Could It be Acute Hepatic Porphyria?
Acute Polyneuropathy With Abdominal Pain: Could It be Acute Hepatic Porphyria?
Elevating the Mood in Major Depressive Disorder (MDD): Optimizing Treatment for Inadequate Initial Responders
Elevating the Mood in Major Depressive Disorder (MDD): Optimizing Treatment for Inadequate Initial Responders
Strategies to Individualize Antidepressant Adjunct Therapy in MDD to Achieve Best Patient Outcomes
Strategies to Individualize Antidepressant Adjunct Therapy in MDD to Achieve Best Patient Outcomes
Shifting Perspectives in the Management of Schizophrenia: Impacting Outcome Through Early Use of Long-Acting Injectables
Shifting Perspectives in the Management of Schizophrenia: Impacting Outcome Through Early Use of Long-Acting Injectables
Stroke Prevention, Type 2 Diabetes, and GLP-1 Receptor Agonists: What Neurologists Need to Know
Stroke Prevention, Type 2 Diabetes, and GLP-1 Receptor Agonists: What Neurologists Need to Know